5-(tert-Butylsulfonyl)-2-(piperidin-1-yl)pyrimidin-4-amine

Catalog No. :
ACCMQP205
CAS No. :
175202-16-1
Molecular Formula :
C13H22N4O2S
Molecular Weight :
298.41

IUPAC Name:5-(tert-butylsulfonyl)-2-(piperidin-1-yl)pyrimidin-4-amine

5-(tert-Butylsulfonyl)-2-(piperidin-1-yl)pyrimidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(tert-Butylsulfonyl)-2-(piperidin-1-yl)pyrimidin-4-amine
IUPAC Name5-(tert-butylsulfonyl)-2-(piperidin-1-yl)pyrimidin-4-amine
Molecular FormulaC13H22N4O2S
Molecular Weight298.41
SMILESNC1=NC(N2CCCCC2)=NC=C1S(=O)(C(C)(C)C)=O
InChI KeyHQQKBPGIADJWIF-UHFFFAOYSA-N
Synonym5-(TERT-BUTYLSULFONYL)-2-PIPERIDINOPYRIMIDIN-4-AMINE;5-(tert-butylsulphonyl)-2-piperidinopyrimidin-4-amine;4-AMINO-5-(TERT-BUTYLSULFONYL)-2-PIPERIDINOPYRIMIDINE;5-(tert-Butylsulfonyl)-2-(piperidin-1-yl)pyriMidin-4-aMine;4-Pyrimidinamine, 5-[(1,1-dimethylethyl)sulfonyl]-2-(1-piperidinyl)-
CAS No.175202-16-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCMQP205 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUFCL270 route compound structure diagram
    ACUFCL270111-24-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCMQP205 route product structure diagram
    ACCMQP205175202-16-1
Inquiry

2. ACCMQP205 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCMQP205 route product structure diagram
    ACCMQP205175202-16-1
Inquiry

Comments (0)